LSDIF (Lucy Scientific Discovery) Total Stockholders Equity: $0.08 Mil (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Lucy Scientific Discovery Total Stockholders Equity?

Lucy Scientific Discovery LSDIF Total Stockholders Equity is $0.08 Mil as of Dec. 2023.

Lucy Scientific Discovery's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $0.08 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Lucy Scientific Discovery's Book Value per Share for the quarter that ended in Dec. 2023 was $0.05. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Lucy Scientific Discovery's Debt-to-Equity for the quarter that ended in Dec. 2023 was 27.32.

Lucy Scientific Discovery  (OTCPK:LSDIF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Lucy Scientific Discovery's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(0.081-0)/1.765
=0.05

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Lucy Scientific Discovery's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1.494 + 0.719) / 0.081
=27.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lucy Scientific Discovery Total Stockholders Equity Related Terms

Lucy Scientific Discovery Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Lucy Scientific Discovery's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lucy Scientific Discovery Total Stockholders Equity Chart

Lucy Scientific Discovery Annual Data
Trend Jun21 Jun22 Jun23
Total Stockholders Equity
-6.36 -4.78 4.68

Lucy Scientific Discovery Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -6.78 5.96 4.68 2.70 0.08
What does a Total Stockholders Equity of $0.08 Mil mean?
Lucy Scientific Discovery (LSDIF) has a Total Stockholders Equity of $0.08 Mil as of Dec. 2023. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Lucy Scientific Discovery and its competitors.
Is Lucy Scientific Discovery's Total Stockholders Equity too high?
Lucy Scientific Discovery's current Total Stockholders Equity is $0.08 Mil.
How does Lucy Scientific Discovery's Total Stockholders Equity compare to INQD and ZTS?
Lucy Scientific Discovery's Total Stockholders Equity of $0.08 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Lucy Scientific Discovery and its competitors. Lucy Scientific Discovery's current Total Stockholders Equity is $0.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lucy Scientific Discovery stock overvalued right now?
Lucy Scientific Discovery (LSDIF) has a current Total Stockholders Equity of $0.08 Mil. The current Total Stockholders Equity is $0.08 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Lucy Scientific Discovery (LSDIF), the current Total Stockholders Equity is $0.08 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lucy Scientific Discovery Business Description

Address 301-1321 Blanshard Street, Victoria, BC, CAN, V8W 0B6
Lucy Scientific Discovery Inc is an early-stage psychotropics contract manufacturing company focused on becoming the contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry. Its drug products are designed to treat a range of mental health and cognitive conditions.